Functional Electrical Stimulation (FES) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Functional Electrical Stimulation (FES) Devices Market Summary

• The global functional electrical stimulation (FES) devices market is expected to increase from USD 690.60 million in 2024 to USD 968.80 million by 2032, reflecting strong and sustained growth.
• The global functional electrical stimulation (FES) devices market is growing at a CAGR of 4.38% during the forecast period from 2025 to 2032.
• The global functional electrical stimulation (FES) devices market is propelled by factors such as the increasing prevalence of neurological disorders and spinal injuries, rising demand for rehabilitation and mobility restoration, favorable healthcare policies and reimbursement frameworks, and the expanding geriatric population, among others.
• The leading companies operating in the functional electrical stimulation devices market include Restorative Therapies, HASOMED GmbH, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MtoMed, Shenzhen XFT Medical Limited, AxioBionics, and others.
• The North American functional electrical stimulation (FES) devices market is witnessing strong growth, driven by a rising prevalence of neurological disorders, including Multiple Sclerosis (MS), cerebral palsy (CP), and traumatic brain injury (TBI), and an increasing demand for advanced rehabilitation solutions to support these patient populations.
• In the product type segment of the functional electrical stimulation (FES) devices market, the wireless devices category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Functional Electrical Stimulation (FES) Devices Market

• Rising prevalence of neurological disorders and injuries leading to a surge in the functional electrical stimulation (FES) devices market: The global rise in neurological conditions such as stroke, spinal cord injury, multiple sclerosis, and cerebral palsy is significantly driving the adoption of FES devices. Stroke remains one of the leading causes of long-term disability, leaving millions of patients with impaired mobility and motor function. Similarly, spinal cord injuries often result in partial or complete paralysis, making rehabilitation technologies essential. FES offers a clinically proven method to restore functional movements and prevent secondary complications like muscle atrophy. As the incidence of these conditions increases worldwide, healthcare providers are investing more in FES-based rehabilitation, thereby boosting market growth.
• Growing demand for rehabilitation and mobility restoration: There is an increasing demand for solutions that help patients regain independence and improve quality of life after neurological impairments. Rehabilitation centers and hospitals are incorporating FES into therapy programs for gait training, hand function recovery, and posture correction. Beyond clinical benefits, FES also provides psychological and social advantages by helping patients perform daily tasks more effectively. The emphasis on mobility restoration is not only enhancing patient outcomes but also pushing healthcare providers and rehabilitation facilities to adopt advanced FES systems, further expanding the market.
• Supportive healthcare policies and reimbursement structures: Government initiatives and supportive reimbursement policies play a crucial role in expanding access to FES devices. In several developed countries, insurance providers and national health systems are increasingly covering FES therapies, reducing the financial burden on patients. This has encouraged hospitals, clinics, and home care providers to integrate these devices into standard treatment protocols. Additionally, research funding and government support for neurorehabilitation projects have accelerated the development of innovative FES technologies. Such supportive frameworks are making these devices more accessible, directly fueling market adoption.

Functional Electrical Stimulation (FES) Devices Market Report Segmentation

This Functional Electrical Stimulation (FES) Devices market report offers a comprehensive overview of the global Functional Electrical Stimulation (FES) Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation of the Functional Electrical Stimulation (FES) Devices Market by Product Type (Wired Devices and Wireless Devices), Indication (Neurological Disorders [Spinal Cord Injury (SCI), Stroke, Multiple Sclerosis, Cerebral Palsy, and Others], Musculoskeletal Disorders [Foot Drop, Muscle Atrophy, and Others], and Others), End-Users (Hospitals & Clinics, Homecare Setting, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing Functional Electrical Stimulation (FES) Devices market.

Functional electrical stimulation devices are advanced therapeutic systems designed to restore or enhance motor function in individuals with neurological impairments. These devices deliver carefully controlled, low-level electrical impulses to specific nerves, prompting the activation and contraction of muscles that have been weakened, immobilized, or paralyzed. By mimicking the body's natural nerve signals, FES helps improve muscle strength, coordination, and functional movement. This technology is particularly beneficial for patients recovering from conditions such as stroke, spinal cord injury, multiple sclerosis, or other disorders that disrupt normal communication between the brain and muscles.

The growth of the functional electrical stimulation devices market is being strongly driven by the rising prevalence of neurological disorders and injuries, including spinal cord injury (SCI), stroke, multiple sclerosis (MS), and spinal muscular atrophy (SMA), which has created a substantial patient population in need of advanced rehabilitation technologies. FES is emerging as a vital solution to restore motor function, improve mobility, and prevent complications such as muscle atrophy. At the same time, the growing demand for rehabilitation and mobility restoration highlights the increasing focus of patients and healthcare providers on interventions that support greater independence, improved daily functioning, and enhanced quality of life.

Supportive healthcare policies and reimbursement frameworks are further accelerating adoption, as government programs, insurance coverage, and funding initiatives reduce financial barriers and encourage the integration of FES devices into hospitals, rehabilitation centers, and home-based care. Additionally, the rapidly expanding geriatric population, which faces higher risks of neurological impairments and limited mobility, is driving sustained demand for long-term rehabilitation solutions, particularly portable and home-use FES devices. Collectively, these trends position FES technology as a cornerstone of modern neurorehabilitation, fueling robust and sustained market growth in the coming years.

What are the latest Functional Electrical Stimulation (FES) Devices Market Dynamics and Trends?

The functional electrical stimulation (FES) devices market is experiencing steady growth, driven by the rising prevalence of neurological disorders, spinal cord injuries, and chronic pain conditions worldwide. FES devices play a critical role in restoring motor function, reducing spasticity, and improving mobility in patients with stroke, multiple sclerosis (MS), cerebral palsy, and spinal cord injuries. With the global population aging and becoming more vulnerable to such impairments, the demand for advanced neurorehabilitation solutions that enhance independence and quality of life is expanding rapidly.

According to DelveInsight, nearly 15.5 million people globally live with spinal cord injuries, largely due to trauma such as falls and accidents, underscoring the urgent need for effective rehabilitation tools like FES. In addition, around 100 million stroke survivors were reported worldwide in 2024, including 56 million women and 45 million men, many of whom suffer long-term motor impairments that can be alleviated through FES therapy. Moreover, over 1.8 million people are affected by MS, a condition associated with progressive muscle weakness and spasticity, while approximately 1.71 billion individuals suffer from musculoskeletal conditions, creating a vast patient pool with functional disabilities. The Spinal Muscular Atrophy (SMA) Foundation also reported in 2023 that 10,000-25,000 children and adults in the U.S. are affected by SMA, further highlighting the growing need for non-invasive FES therapies to maintain muscle function and slow disease progression.

The prevalence of degenerative and neurological disorders is particularly high in developed regions such as the U.S. and Europe, where robust healthcare infrastructure, favourable reimbursement policies, and greater awareness of advanced rehabilitation technologies drive adoption. In such settings, when conventional approaches like medication or physical therapy prove insufficient, FES is increasingly integrated into rehabilitation programs to support motor recovery and patient independence.

Meanwhile, continuous product innovation, including the launch of wireless, AI-enabled, and home-based FES systems, is improving convenience, patient compliance, and clinical outcomes, further strengthening market growth.

Despite these opportunities, challenges remain. Risks such as muscle fatigue, skin irritation, or discomfort may hinder patient adherence, while competition from alternative rehabilitation methods (physical therapy, orthotic devices, robotic rehabilitation systems) and regulatory hurdles could slow adoption. Nevertheless, the combination of a rapidly expanding patient base, supportive reimbursement frameworks, and ongoing technological advancements is expected to fuel robust growth of the global FES devices market between 2025 and 2032.

Functional Electrical Stimulation (FES) Devices Market Segment Analysis

Functional Electrical Stimulation (FES) Devices Market by Product Type (Wired Devices and Wireless Devices), Indication (Neurological Disorders [Spinal Cord Injury (SCI), Stroke, Multiple Sclerosis, Cerebral Palsy, and Others], Musculoskeletal Disorders [Foot Drop, Muscle Atrophy, and Others], and Others), End-Users (Hospitals & Clinics, Homecare Setting, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product Type: Wireless Devices Category Dominates the Market

The wireless devices category is the dominant force in the functional electrical stimulation (FES) devices market. In 2024, wireless devices accounted for a significant share of approximately 59%. The Wireless device segment dominates the product type segment in the functional electrical stimulation (FES) devices market owing to its unmatched portability, ease of use, and suitability for both clinical and home-based rehabilitation. Unlike traditional wired systems, wireless devices enhance patient comfort and mobility by removing the restrictions of cables, leading to higher compliance and better therapy outcomes. These devices are increasingly integrated with Bluetooth and app-based platforms, allowing clinicians and patients to monitor and adjust therapy parameters in real time.

Leading products such as Bioness L300 Go(R), widely recognized for lower-limb rehabilitation, and the Bioness H200 Wireless Hand Rehabilitation System, which recently received FDA clearance for upper-limb therapy, have significantly strengthened the adoption of wireless solutions.

Additionally, companies like Hasomed with its RehaStim(R)3 platform and Odstock Medical's next-generation ODSTIM(R) systems are expanding their wireless portfolios with improved ergonomics and clinical features. The growing demand for home-based neurorehabilitation, supported by recent regulatory approvals and continuous product innovations, positions wireless devices as the frontrunners in the market.

Consequently, their dominance in the product type segment is not only reshaping patient care but also propelling overall market growth by improving accessibility, clinical efficacy, and long-term adoption.

By Indication: Neurological Disorders Dominate the Market

In the functional electrical stimulation devices market, the neurological disorders category held the largest market share, capturing nearly 65% of the global market in 2024. This is due to the rising prevalence of conditions such as stroke, spinal cord injury, traumatic brain injury, cerebral palsy, and multiple sclerosis, which significantly impair motor functions and mobility. These disorders often result in muscle weakness, paralysis, or loss of motor control, making FES devices an essential therapeutic solution to restore functionality, improve mobility, and enhance quality of life.

Moreover, the growing aging population is more susceptible to neurological diseases, further driving demand. Clinical studies and evidence-based outcomes have reinforced the efficacy of FES in rehabilitation, leading to greater adoption by hospitals, rehabilitation centers, and even home-based care settings. Coupled with increasing awareness, technological advancements such as wireless, portable, and AI-enabled FES devices have widened their use in neurorehabilitation. As a result, the strong clinical need, combined with supportive innovation and healthcare adoption, positions neurological disorders as the dominant segment that significantly boosts market growth.

By End-Users: Hospitals & Clinics Dominate the Market

The hospitals and clinics category dominates the end-user segment in the Functional Electrical Stimulation (FES) devices market owing to their well-established infrastructure, access to advanced rehabilitation technologies, and availability of trained medical professionals. These facilities serve as the primary centers for patients with neurological conditions, spinal cord injuries, strokes, and musculoskeletal disorders, where FES therapy is integrated into comprehensive rehabilitation programs. Hospitals and clinics are also better positioned to adopt innovative FES systems due to higher budgets and supportive reimbursement frameworks, which enhance patient accessibility.

Additionally, the presence of multidisciplinary teams, including neurologists, physiotherapists, and rehabilitation specialists, ensures that FES therapies are optimally tailored to patient needs, resulting in improved clinical outcomes. The growing demand for post-stroke and neurorehabilitation services, coupled with rising investments in advanced therapeutic equipment across hospitals and clinics, further strengthens their dominance in this segment.

As a result, the increasing integration of FES devices into clinical rehabilitation pathways is significantly boosting the overall market growth.

Functional Electrical Stimulation (FES) Devices Market Regional Analysis

North America Functional Electrical Stimulation (FES) Devices Market Trends

North America, led by the United States, dominates the global functional electrical stimulation devices market, accounting for approximately 45% of the total market share in 2024. The North American functional electrical stimulation devices market is witnessing strong growth, driven by a rising prevalence of neurological disorders, including Multiple Sclerosis (MS), cerebral palsy (CP), and traumatic brain injury (TBI), and an increasing demand for advanced rehabilitation solutions to support these patient populations.

According to DelveInsight analysis (2025), in 2024, approximately 920,000 adults in the United States were living with a diagnosis of multiple sclerosis, with this figure projected to increase steadily over the next decade, reflecting a growing need for effective rehabilitation devices.

Similarly, cerebral palsy affects around 1.5 million individuals of all ages in the U.S., many of whom can benefit from FES therapy to improve muscle strength, enhance mobility, and facilitate better motor control, particularly in the lower limbs.

Furthermore, traumatic brain injuries remain highly prevalent, with over 586 TBI-related hospitalizations per day in the U.S., highlighting an urgent demand for interventions that restore functional independence and support long-term rehabilitation.

In addition to the rising patient population, the North American market benefits from a strong healthcare infrastructure, favorable reimbursement policies, and growing awareness of advanced rehabilitation technologies. These factors collectively enable broader adoption of FES devices across hospitals, specialized rehabilitation centers, and home care settings.

The convergence of these epidemiological trends, supportive healthcare frameworks, and technological advancements positions North America as a key and rapidly expanding market for FES devices, presenting substantial growth opportunities for manufacturers, service providers, and healthcare stakeholders. The interplay of these factors is expected to create a highly conducive environment for market expansion throughout the forecast period.

Europe Functional Electrical Stimulation (FES) Devices Market Trends

The Europe Functional Electrical Stimulation (FES) Devices market is growing steadily, supported by a combination of demographic, clinical, and technological factors. The rising prevalence of neurological disorders such as stroke, spinal cord injury, multiple sclerosis, and cerebral palsy has significantly increased the need for advanced rehabilitation solutions across the region. Europe's rapidly aging population further contributes to this demand, as elderly individuals are more prone to mobility impairments and long-term functional disabilities that require specialized therapy. The region also benefits from strong healthcare infrastructure and supportive reimbursement frameworks, with several government-backed rehabilitation programs helping patients gain access to innovative therapies.

Alongside this, continuous technological advancements in FES devices, including wireless, portable, and AI-driven systems, are improving treatment outcomes, reducing patient dependency, and enabling wider use in both clinical and home care settings. Moreover, Europe has been at the forefront of research collaborations and clinical trials, which have enhanced clinical validation and encouraged faster adoption of these devices. Growing awareness of the benefits of neurorehabilitation, coupled with increasing healthcare spending and emphasis on improving quality of life, is encouraging hospitals, rehabilitation centers, and patients to adopt FES therapies more widely.

Collectively, these trends are positioning Europe as one of the most important regions for the FES devices market, offering significant opportunities for innovation, expansion, and long-term growth for both manufacturers and healthcare providers.

Asia-Pacific Functional Electrical Stimulation (FES) Devices Market Trends

The Asia-Pacific functional electrical stimulation (FES) devices market is witnessing rapid expansion, reflecting a robust CAGR during the forecast period from 2025 to 2032, driven by rising healthcare awareness, increasing incidence of neurological disorders, and rapid improvements in healthcare infrastructure. Countries such as China, India, and Japan are witnessing a surge in cases of stroke, spinal cord injuries, and age-related mobility impairments, creating strong demand for advanced rehabilitation solutions like FES. The region's expanding geriatric population is further driving adoption, as elderly individuals are more susceptible to neurodegenerative conditions and require long-term mobility support.

Additionally, growing healthcare investments, government initiatives to promote rehabilitation care, and the gradual expansion of reimbursement policies are making these devices more accessible to patients. The market is also benefiting from technological advancements and the entry of global as well as local manufacturers, who are introducing portable and cost-effective FES devices tailored to regional needs.

Therefore, with increasing awareness of the benefits of neurorehabilitation, rising disposable incomes, and a growing focus on home care solutions, the Asia-Pacific is poised to become a key contributor to the global FES devices market in the coming years, offering vast opportunities for expansion and innovation.

Who are the major players in the Functional Electrical Stimulation (FES) Devices Market?

The following are the leading companies in the Functional Electrical Stimulation (FES) Devices market. These companies collectively hold the largest market share and dictate industry trends.

• Restorative Therapies
• HASOMED GmbH
• Bioness Inc.
• Trulife
• Otto Bock
• Odstock Medical Limited
• Hobbs Rehabilitation
• MtoMed
• Shenzhen XFT Medical Limited
• AxioBionics

How is the competitive landscape shaping the Functional Electrical Stimulation (FES) Devices Market?

The competitive landscape of the functional electrical stimulation (FES) devices market is shaped by the presence of both global medical device companies and regional players, each striving to expand their footprint through product innovation, strategic collaborations, and clinical research initiatives. Leading manufacturers are focusing on developing wireless, portable, and AI-integrated FES systems to enhance usability, improve patient compliance, and support home-based rehabilitation.

At the same time, partnerships with rehabilitation centers, academic institutions, and healthcare providers are enabling companies to strengthen clinical validation and increase adoption. Market players are also investing in expanding their distribution networks to tap into high-growth regions such as Asia-Pacific and Latin America. Despite these advancements, the FES devices market remains fragmented, with numerous small and mid-sized companies competing alongside established players, creating opportunities for innovation but also intensifying competition.

Recent Developmental Activities in the Functional Electrical Stimulation (FES) Devices Market

• In June 2025, Bioness Medical, Inc., a leading neuro-rehabilitation company dedicated to enhancing and restoring function for individuals with neurological and orthopedic impairments, announced the acquisition of the assets and business of Harmonic Bionics, Inc., a robotics company based in Austin, Texas. Harmonic Bionics specializes in improving upper extremity mobility and functional recovery in patients following neurological events such as stroke and traumatic brain injury, further strengthening Bioness's portfolio in advanced neuro-rehabilitation solutions.
• In April 2025, ReShape Lifesciences(R), a leading physician-led company specializing in weight loss and metabolic health solutions, announced an agreement with Motion Informatics, based in Haifa, Israel, to exclusively import and distribute their next-generation neuromuscular rehabilitation devices in the U.S.
• In January 2024, Evolution Devices, Inc. announced that the EvoWalk 1.0 System received FDA 510(k) clearance, permitting its commercial sale in the United States. The EvoWalk is a non-invasive, wearable functional electrical stimulation (FES) device designed to support ankle dorsiflexion and assist with knee flexion or extension in adults experiencing foot drop or muscle weakness caused by upper motor neuron conditions or injuries, such as stroke, multiple sclerosis, or spinal cord pathway damage.

Functional Electrical Stimulation (FES) Devices Market Segmentation

• Functional Electrical Stimulation (FES) Devices by Product Type Exposure
• Wired Devices
• Wireless Devices
• Functional Electrical Stimulation (FES) Devices by Indication Exposure
• Neurological Disorders
• Spinal Cord Injury (SCI)
• Stroke
• Multiple Sclerosis
• Cerebral Palsy
• Others
• Musculoskeletal Disorders
• Foot Drop
• Muscle Atrophy
• Other
• Others
• Functional Electrical Stimulation (FES) Devices End-Users Exposure
• Hospitals & Clinics
• Homecare Setting
• Others
• Functional Electrical Stimulation (FES) Devices Geography Exposure
• North America Functional Electrical Stimulation (FES) Devices Market
• United States Functional Electrical Stimulation (FES) Devices Market
• Canada Functional Electrical Stimulation (FES) Devices Market
• Mexico Functional Electrical Stimulation (FES) Devices Market
• Europe Functional Electrical Stimulation (FES) Devices Market
• United Kingdom Functional Electrical Stimulation (FES) Devices Market
• Germany Functional Electrical Stimulation (FES) Devices Market
• France Functional Electrical Stimulation (FES) Devices Market
• Italy Functional Electrical Stimulation (FES) Devices Market
• Spain Functional Electrical Stimulation (FES) Devices Market
• Rest of Europe Functional Electrical Stimulation (FES) Devices Market
• Asia-Pacific Functional Electrical Stimulation (FES) Devices Market
• China Functional Electrical Stimulation (FES) Devices Market
• Japan Functional Electrical Stimulation (FES) Devices Market
• India Functional Electrical Stimulation (FES) Devices Market
• Australia Functional Electrical Stimulation (FES) Devices Market
• South Korea Functional Electrical Stimulation (FES) Devices Market
• Rest of Asia-Pacific Functional Electrical Stimulation (FES) Devices Market
• Rest of the World Functional Electrical Stimulation (FES) Devices Market
• South America Functional Electrical Stimulation (FES) Devices Market
• Middle East Functional Electrical Stimulation (FES) Devices Market
• Africa Functional Electrical Stimulation (FES) Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

Artificial intelligence (AI) is increasingly transforming the Functional Electrical Stimulation (FES) devices market by enabling smarter, more personalized, and efficient rehabilitation solutions. AI-powered FES systems leverage machine learning algorithms and sensor data to analyze patient-specific movement patterns, muscle responses, and therapy progress, allowing real-time adjustments in stimulation intensity, timing, and targeting of muscle groups. This personalization enhances treatment efficacy, reduces the risk of over-stimulation or fatigue, and improves patient comfort and compliance.

Key applications include gait training and mobility restoration, where AI optimizes lower-limb stimulation for patients with stroke, spinal cord injuries, or cerebral palsy, improving walking patterns and balance, as well as upper limb rehabilitation, assisting in fine motor control, hand grasp, and arm movement by dynamically adapting stimulation based on muscle performance and patient feedback. AI integration also supports home-based and remote rehabilitation, enabling clinicians to monitor progress and adjust therapy remotely, and predictive therapy, where historical therapy data is analyzed to forecast recovery trajectories and help set realistic functional goals. Therefore, AI-powered FES devices are enhancing clinical outcomes, reducing therapy time, and expanding accessibility, representing a significant advancement in neurorehabilitation technology and creating new growth opportunities in the FES devices market.

U.S. Tariff Impact Analysis on the Functional Electrical Stimulation (FES) Devices Market:

The imposition of U.S. tariffs on imported Functional Electrical Stimulation (FES) devices has introduced notable challenges for the market. Increased import costs can lead to higher prices for hospitals, rehabilitation centers, and home care providers, potentially affecting adoption rates, particularly in budget-sensitive outpatient settings. Domestic manufacturers may benefit from reduced competition from imports, allowing them to expand market share, but companies relying on global supply chains face higher production costs, which could impact profit margins and delay the launch of new devices.

Tariffs also influence strategic decisions, including sourcing strategies, investment in local manufacturing, and pricing models. International players may reconsider market entry or expand U.S.-based production to mitigate tariff effects, while domestic companies may accelerate innovation to capitalize on market opportunities. Despite these challenges, the U.S. FES market continues to grow, driven by the rising prevalence of neurological disorders, chronic pain, cerebral palsy, and traumatic brain injuries. Since tariffs add a layer of financial and operational complexity, the strong demand for advanced rehabilitation solutions ensures that market expansion and innovation remain on track.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Functional Electrical Stimulation (FES) Devices market report study

• Market size analysis for the current functional electrical stimulation (FES) devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the functional electrical stimulation (FES) devices market.
• Various opportunities available for the other competitors in the functional electrical stimulation (FES) devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current functional electrical stimulation (FES) devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the functional electrical stimulation (FES) devices market growth in the future?

Frequently Asked Questions for the Functional Electrical Stimulation (FES) Devices Market

1. What is the growth rate of the functional electrical stimulation (FES) devices market?

• The functional electrical stimulation (FES) devices market is estimated to grow at a CAGR of 4.38% during the forecast period from 2025 to 2032.

2. What is the market for functional electrical stimulation (FES) devices?

• The functional electrical stimulation (FES) devices market was valued at USD 665.40 million in 2024, and is expected to reach USD 968.80 million by 2032.

3. Which region has the highest share in the functional electrical stimulation (FES) devices market?

• The North American functional electrical stimulation (FES) devices market is witnessing strong growth, driven by a rising prevalence of neurological disorders, including Multiple Sclerosis (MS), cerebral palsy (CP), and traumatic brain injury (TBI), and an increasing demand for advanced rehabilitation solutions to support these patient populations.

4. What are the drivers for the functional electrical stimulation (FES) devices market?

• The global functional electrical stimulation (FES) devices market is propelled by factors such as the increasing prevalence of neurological disorders and injuries, rising demand for rehabilitation and mobility restoration, favorable healthcare policies and reimbursement frameworks, and the expanding geriatric population, among others.

5. Who are the key players operating in the functional electrical stimulation (FES) devices market?

• Some of the key market players operating in the functional electrical stimulation devices market include Restorative Therapies, HASOMED GmbH, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MtoMed, Shenzhen XFT Medical Limited, AxioBionics, and Others.